Part of the series: Allergy, Asthma & Immunology Innovations Podcast
This podcast was made in partnership with Allergy & Asthma Network, with funding support from AstraZeneca.
In this episode, we explore a new form of asthma treatment, Biologics. These innovative treatments offer targeted relief by addressing the underlying causes of asthma, leading to improved symptom control and a better quality of life. Dr. G and Kortney discuss the current biologics on the market for asthma treatment. 
As this is a true deep dive, we have provided some more information about the Biologics discussed to help you build a better understanding. We have included images and graphs you can use when listening to the episode. 
What we cover in this episode:
A background on how Biologic treatments work.
The Biologics available for asthma - discuss who is a candidate, how they each work, how they are taken and some side effects. Omalizumab (Xolair)
Mepolizumab
Reslizumab
Benralizumab
Dupilumab
Tezepelumab



Helpful links:
Images and graphs discussed in this episode: www.itchpodcast.com/episodes/56-asthma-biologics
A look at biologics in more depth: www.biologicmeds.org
More about type 2 inflammation: https://allergyasthmanetwork.org/news/when-asthma-more-than-asthma-type-inflammation/